You are here

Article Text

Article menu
Download PDFPDF
Correspondence
A little bit more on the slide
  1. P J Carder1,
  2. J C Liston2
  1. 1Department of Pathology, St James’s University Hospital, Beckett Street, Leeds LS9 7TF, UK; paulinecarder@doctors.org.uk
  2. 2Leeds-Wakefield Breast Screening Programme, Leeds, UK

    https://doi.org/10.1136/jcp.56.9.720

    Statistics from Altmetric.com

      Request Permissions

      If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

      In 2001–2, 89% of cancers detected by the UK National Health Service Breast Screening Programme (NHSBSP) were diagnosed preoperatively.1 In 1996–7, the figure was 63%. Year on year increases in the preoperative diagnosis rate have parallelled the increasing use of needle core biopsy (NCB). There has been a threefold increase (from 17% to 66%) in the proportion of cancers diagnosed by a B5 NCB over this period. The proportion of cases …

      View Full Text